• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺微钙化:英国 RCR 五分制乳腺影像学系统或 BI-RADS;哪个是恶性肿瘤更好的预测指标?

Breast microcalcifications: the UK RCR 5-point breast imaging system or BI-RADS; which is the better predictor of malignancy?

机构信息

Department of Radiology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.

Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.

出版信息

Br J Radiol. 2019 Nov;92(1103):20190177. doi: 10.1259/bjr.20190177. Epub 2019 Aug 9.

DOI:10.1259/bjr.20190177
PMID:31365279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6849664/
Abstract

OBJECTIVE

In the UK RCR 5-point breast imaging system (UKS), radiologists grade mammograms from 1 to 5 according to suspicion for malignancy, however unlike BI-RADS, no lexicon of descriptors is published. The aim of this study was to determine whether strict categorisation of microcalcifications (MCC) according to BI-RADS was a better predictor of malignancy than the UKS and whether these descriptors could be used within the UKS.

METHODS

A retrospective review of 241 cases, with MCC on mammography, who underwent biopsy was performed. Morphology, distribution, extent, UKS score, BI-RADS category and pathology were recorded. The positive predictive value (PPV) of each classification system for malignancy was calculated.

RESULTS

28.6% were diagnosed with DCIS/IDC. The PPV for malignancy using the UKS was 18.9%, 69.4%, 100% for M3-5 respectively ( < 0.001) and using ΒI-RADS morphology was amorphous: 7.1%, coarse heterogeneous: 33.3%, fine pleomorphic: 48.1% and fine linear/fine linear branching: 85.2% ( < 0.001). The PPV based on distribution was grouped: 14.2%, regional: 32.3%, diffuse: 33.3% and linear/segmental: 77.8% ( < 0.001). Combining all cases of benign-appearing, amorphous and grouped coarse heterogenous and grouped fine pleomorphic MCC gave a PPV of 12.8%. Combining regional, linear or segmental coarse heterogenous and fine pleomorphic and all fine linear/branching MCC resulted in a PPV of 83.3% for malignancy.

CONCLUSION

Combining morphology and distribution of MCC is accurate in malignancy prediction. Use of BI-RADS descriptors could help standardise reporting within the UKS and an algorithm using these within the UKS is proposed. Better prediction would enable more appropriate counselling and help to identify discrepancies.

ADVANCES IN KNOWLEDGE

No guidance exists on scoring of suspicious MCC in the UK breast imaging system. Use of BI-RADS morphologic/distribution descriptors can aid malignancy prediction. Findings other than morphology of MCC are important in malignancy prediction. An algorithm for use by the UK radiologist when evaluating MCC is provided.

摘要

目的

在英国 RCR 五分制乳腺成像系统(UKS)中,放射科医生根据恶性肿瘤的可疑程度将乳腺 X 线摄影图像从 1 分到 5 分进行分级,但是与 BI-RADS 不同的是,没有公布描述符词汇表。本研究的目的是确定根据 BI-RADS 对微钙化(MCC)进行严格分类是否比 UKS 更能预测恶性肿瘤,以及这些描述符是否可以在 UKS 中使用。

方法

对 241 例接受活检的乳腺 X 线摄影有 MCC 的病例进行回顾性研究。记录形态、分布、范围、UKS 评分、BI-RADS 类别和病理学。计算每个分类系统对恶性肿瘤的阳性预测值(PPV)。

结果

28.6%的病例被诊断为 DCIS/IDC。使用 UKS 诊断恶性肿瘤的 PPV 分别为 18.9%、69.4%、100%(<0.001),使用 BI-RADS 形态学为无定形:7.1%、粗不均匀:33.3%、细多形性:48.1%和细线性/细线性分支:85.2%(<0.001)。基于分布的 PPV 为分组:14.2%、区域性:32.3%、弥漫性:33.3%和线性/节段性:77.8%(<0.001)。将良性外观、无定形和分组性粗不均匀及分组性细多形性的所有 MCC 病例相结合,其 PPV 为 12.8%。将区域性、线性或节段性粗不均匀和细多形性以及所有细线性/分支性 MCC 相结合,恶性肿瘤的 PPV 为 83.3%。

结论

MCC 的形态和分布相结合可准确预测恶性肿瘤。使用 BI-RADS 描述符可有助于在 UKS 中标准化报告,并且提出了一种在 UKS 中使用这些描述符的算法。更好的预测可以使更适当的咨询,并有助于识别差异。

知识进展

在英国乳腺成像系统中,对可疑 MCC 评分没有指导。使用 BI-RADS 形态学/分布描述符可以帮助预测恶性肿瘤。MCC 的形态以外的发现对恶性肿瘤的预测很重要。提供了一种供英国放射科医生在评估 MCC 时使用的算法。

相似文献

1
Breast microcalcifications: the UK RCR 5-point breast imaging system or BI-RADS; which is the better predictor of malignancy?乳腺微钙化:英国 RCR 五分制乳腺影像学系统或 BI-RADS;哪个是恶性肿瘤更好的预测指标?
Br J Radiol. 2019 Nov;92(1103):20190177. doi: 10.1259/bjr.20190177. Epub 2019 Aug 9.
2
Evaluation of malignancy risk stratification of microcalcifications detected on mammography: a study based on the 5th edition of BI-RADS.乳腺钼靶检查发现的微钙化灶恶性风险分层评估:一项基于第5版乳腺影像报告和数据系统(BI-RADS)的研究
Ann Surg Oncol. 2015 Sep;22(9):2895-901. doi: 10.1245/s10434-014-4362-6. Epub 2015 Jan 22.
3
The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories.BI-RADS 微钙化描述符和最终评估类别阳性预测值。
AJR Am J Roentgenol. 2010 May;194(5):1378-83. doi: 10.2214/AJR.09.3423.
4
"Category 4A" microcalcifications: how should this subcategory be applied to microcalcifications seen on mammography?4A类微钙化:该亚类应如何应用于乳腺钼靶检查中所见的微钙化?
Acta Radiol. 2018 Feb;59(2):147-153. doi: 10.1177/0284185117709036. Epub 2017 May 10.
5
Qualitative Radiogenomics: Association Between BI-RADS Calcification Descriptors and Recurrence Risk as Assessed by the Oncotype DX Ductal Carcinoma In Situ Score.定性放射组学:BI-RADS 钙化描述符与 Oncotype DX 导管原位癌评分评估的复发风险之间的关联。
AJR Am J Roentgenol. 2019 Apr;212(4):919-924. doi: 10.2214/AJR.18.20306. Epub 2019 Feb 4.
6
Usefulness and limitations of the Japan Mammography Guidelines for the categorization of microcalcifications.日本乳腺钼靶摄影指南对微钙化进行分类的实用性与局限性
Breast Cancer. 2008;15(4):291-7. doi: 10.1007/s12282-008-0033-4. Epub 2008 Feb 21.
7
Scoring system based on BI-RADS lexicon to predict probability of malignancy in suspicious microcalcifications.基于 BI-RADS 词汇的评分系统预测可疑微钙化恶性肿瘤的概率。
Ann Surg Oncol. 2012 May;19(5):1491-8. doi: 10.1245/s10434-011-2167-4. Epub 2011 Dec 16.
8
Comparison of Positive Predictive Values of Categorization of Suspicious Calcifications Using the 4th and 5th Editions of BI-RADS.第四版和第五版 BI-RADS 对可疑钙化分类的阳性预测值比较。
AJR Am J Roentgenol. 2019 Sep;213(3):710-715. doi: 10.2214/AJR.18.20866. Epub 2019 May 7.
9
Detection and diagnosis of automated breast ultrasound in patients with BI-RADS category 4 microcalcifications: a retrospective study.BI-RADS 4 类微钙化患者自动乳腺超声检测与诊断:一项回顾性研究。
BMC Med Imaging. 2024 May 28;24(1):126. doi: 10.1186/s12880-024-01287-4.
10
Breast microcalcifications as type descriptors to stratify risk of malignancy: a systematic review and meta-analysis of 10665 cases with special focus on round/punctate microcalcifications.作为恶性风险分层类型描述符的乳腺微钙化:对10665例病例的系统评价和荟萃分析,特别关注圆形/点状微钙化
Rofo. 2012 Dec;184(12):1144-52. doi: 10.1055/s-0032-1313102. Epub 2012 Aug 24.

引用本文的文献

1
Clinicopathological and prognostic value of calcification morphology descriptors in ductal carcinoma in situ of the breast: a systematic review and meta-analysis.乳腺导管原位癌中钙化形态描述符的临床病理及预后价值:一项系统评价与Meta分析
Insights Imaging. 2023 Dec 5;14(1):213. doi: 10.1186/s13244-023-01529-z.
2
Amorphous breast calcifications: is BI-RADS 4a appropriate?乳腺无定形钙化:BI-RADS 4a分类是否合适?
Radiol Bras. 2023 Mar-Apr;56(2):75-80. doi: 10.1590/0100-3984.2022.0085-en.
3
Clinical and pathological features analysis of invasive breast cancer with microcalcification.伴有微钙化的浸润性乳腺癌的临床和病理特征分析。
Cancer Med. 2023 May;12(10):11351-11362. doi: 10.1002/cam4.5848. Epub 2023 Mar 27.

本文引用的文献

1
High risk (B3) breast lesions: What is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis.高风险(B3)乳腺病变:各病变亚型的恶性肿瘤发生率是多少?系统评价和荟萃分析。
Eur J Surg Oncol. 2019 Apr;45(4):519-527. doi: 10.1016/j.ejso.2018.12.008. Epub 2018 Dec 11.
2
A comparison of full-field digital mammograms versus 2D synthesized mammograms for detection of microcalcifications on screening.全数字化乳腺钼靶摄影与 2D 合成钼靶摄影在筛查中对微钙化检测的比较。
Eur J Radiol. 2018 Oct;107:14-19. doi: 10.1016/j.ejrad.2018.08.004. Epub 2018 Aug 10.
3
Screening women with a personal history of breast cancer: overview of the evidence on breast imaging surveillance.对有乳腺癌个人病史的女性进行筛查:乳腺影像监测证据综述
Ultrasonography. 2018 Oct;37(4):277-287. doi: 10.14366/usg.18017. Epub 2018 Jun 7.
4
Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.乳腺癌筛查在高于平均风险的女性中的应用:来自 ACR 的建议。
J Am Coll Radiol. 2018 Mar;15(3 Pt A):408-414. doi: 10.1016/j.jacr.2017.11.034. Epub 2018 Jan 19.
5
Suspicious breast calcifications undergoing stereotactic biopsy in women ages 70 and over: Breast cancer incidence by BI-RADS descriptors.70岁及以上女性中接受立体定向活检的可疑乳腺钙化灶:按BI-RADS分类的乳腺癌发病率
Eur Radiol. 2017 Jun;27(6):2275-2281. doi: 10.1007/s00330-016-4617-7. Epub 2016 Oct 17.
6
Imaging and Histopathologic Features of BI-RADS 3 Lesions Upgraded during Imaging Surveillance.影像监测期间升级的BI-RADS 3类病变的影像学和组织病理学特征
Breast J. 2017 Jan;23(1):10-16. doi: 10.1111/tbj.12677. Epub 2016 Sep 9.
7
Frequency of Discordant Lesions and False-negative Cancers at Stereotactic Vacuum-assisted Biopsy.立体定向真空辅助活检中不一致病变和假阴性癌症的发生率
Acad Radiol. 2016 Aug;23(8):994-9. doi: 10.1016/j.acra.2016.03.023. Epub 2016 May 5.
8
Evaluation of malignancy risk stratification of microcalcifications detected on mammography: a study based on the 5th edition of BI-RADS.乳腺钼靶检查发现的微钙化灶恶性风险分层评估:一项基于第5版乳腺影像报告和数据系统(BI-RADS)的研究
Ann Surg Oncol. 2015 Sep;22(9):2895-901. doi: 10.1245/s10434-014-4362-6. Epub 2015 Jan 22.
9
Atypical hyperplasia of the breast--risk assessment and management options.乳腺非典型增生——风险评估与管理选择
N Engl J Med. 2015 Jan 1;372(1):78-89. doi: 10.1056/NEJMsr1407164.
10
Management of women at high risk of breast cancer.乳腺癌高危女性的管理。
BMJ. 2014 Apr 28;348:g2756. doi: 10.1136/bmj.g2756.